JUL 02, 2019 01:21 PM PDT

Anticholinergic Drugs and Dementia?

WRITTEN BY: Nouran Amin

A link between anticholinergic drug use and cognitive impairment was recently observed from observational studies on randomized clinical trials. Regenstrief Institute research scientists examined whether anticholinergic drugs can lead to dementia and if cholinergic neurotransmission can be improved. Commentary published in JAMA Internal Medicine explains how researchers identify anticholinergic drug use as a potential public health concern and risk factor for dementia.

Anticholinergic-based medicines work by inhibiting the neurotransmitter acetylcholine and used for the treatment of anxiety, depression, and certain types of pain as well as allergies or sleep problems. They are frequently prescribed to older adults.

Learn more about anticholinergic pharmacology:

"Though we learn about potential risk factors through observational studies, the best way to define a causal relationship between anticholinergics and dementia requires a prospective, randomized trial," states lead author, Dr. Noll Campbell. "In conducting such a trial, we can also learn about the risks and benefits of deprescribing medications, including the impact on symptom control, withdrawal or other adverse events, quality of life, and healthcare utilization."

In the commentary, researchers call for the opportunity to understand the cognitive benefit of deprescribing anticholinergics. They identify ideal drug targets for reducing the anticholinergic burden which includes: “(1) high risk of harm, (2) commonly used and (3) existence of an alternative drug to manage the patient's medical condition, if necessary.”

"Clinicians, health policy makers and patients need to understand the benefits and harms of deprescribing anticholinergics," Dr. Campbell added. "The bottom line is that we need as much high-quality evidence to understand risks and benefits of deprescribing a medication as we have to prescribe it. At the same time, we need to be exploring alternative medications which are known not to harm the aging brain and that patients can afford."

Source: Regenstrief.org

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 19, 2020
Cancer
JAN 19, 2020
Using senolytics to treat cancer
New research published in Nature Metabolism proposes using an already existing drug – a cardiac glycoside called ouabain – as a senolytic to ki...
JAN 19, 2020
Health & Medicine
JAN 19, 2020
FDA Cautions Against Cannabis Use During Pregnancy
A recent article published by NPR addresses the rapidly growing number of females using cannabis during pregnancy. Those with tough pregnancy side effects ...
JAN 19, 2020
Drug Discovery & Development
JAN 19, 2020
Improving Vaccines for Meningitis
Scientists at the University of Nottingham are seeking new ways to improve vaccine use in the protection against the bacterium, Neisseria meningitides that...
JAN 19, 2020
Drug Discovery & Development
JAN 19, 2020
Designing Drugs To Fight off C. Diff Infections
A study published by PNAS explains breakthrough research around designing drugs that target C. diff bacterial infections that result in 15,000 deaths in th...
JAN 19, 2020
Cancer
JAN 19, 2020
Could the flu vaccine shrink cancer tumors?
If you’ve been to the doctor recently, you’ve probably been asked if you want a flu shot this year. The flu vaccine is popular because it reduc...
JAN 19, 2020
Cancer
JAN 19, 2020
FLASH proton therapy: faster and more effective
A new technique called FLASH proposes a new type of radiation therapy. The technique is composed of an ultra-high dose rate of radiotherapy and uses electr...
Loading Comments...